1 to 9 of 32 results

The earning potentials of needle-free delivery methods

The earning potentials of needle-free delivery methods


Here's our take on the week's top stories.

Antibiotics and Infectious diseasesDrug delivery technologiesMedical equipmentNeedle-free devicesPatentsProductionVaccines

Joint purchasing of vaccines and medicines becomes a reality in the EU

Joint purchasing of vaccines and medicines becomes a reality in the EU


The European Commission today approved a Joint Procurement Agreement, which will enable all European…

Antibiotics and Infectious diseasesEuropeFinancialMarkets & MarketingPharmaceuticalVaccines

Positive top-line results for Pfizer’s Prevenar 13 in pneumonia in over 65s


US pharma behemoth Pfizer says that top-line results from a study of Prevenar 13 (pneumococcal 13-valent…

Antibiotics and Infectious diseasesPfizerPharmaceuticalPrevenarResearchVaccines

Valneva initiates fourth antibody discovery program for Sanofi Pasteur


European biotechnology company Valneva has initiated a fourth monoclonal antibody discovery program for…

Antibiotics and Infectious diseasesBiotechnologyLicensingResearchSanofiSanofi PasteurVaccinesValneva

Leading Chinese hepatitis B vaccine makers stop production; Pfizer drug import halted


China’s Food and Drug Administration announced on January 2 that the country’s three leading manufacturers…

Anti-viralsAntibiotics and Infectious diseasesAsia-PacificBioKangtaiChinaFluconazolePfizerPharmaceuticalRegulationVaccines

ProJect Pharma and TUM-spin-off link on H. pylori vaccine development


Germany-based ProJect Pharmaceutics has signed a development agreement with ImevaX, a spin-off project…

Antibiotics and Infectious diseasesImevaXLicensingPharmaceuticalProJect PharmaceuticsResearchVaccines

Infectious disease treatments market driven by growth in middle-income to low-income countries


The infectious disease treatments market increased at a compound annual growth rate (CAGR) of 6.9% between…

Antibiotics and Infectious diseasesGlobalMarkets & MarketingPharmaceuticalVaccines

GlaxoSmithKline and Abbott to start production in Ukraine


UK pharma giant GlaxoSmithKline (LSE: GSK) and the USA's Abbott (NYSE: ABT) are considering launching…

Anti-viralsAntibiotics and Infectious diseasesEuropeGlaxoSmithKlineIndarPharmaceuticalProductionVaccines

1 to 9 of 32 results



Back to top